Skip to Main Content

Paper Details

Tissue-resident memory and circulating T cells are early responders to pre-surgical cancer immunotherapy.
Cell
106
2022
CD8 T, CTLA-4, KLRG1, MAGEA1, PD-1, PD-1-positive KLRG1-negative T cells, Tumor, Tumor-, Tumor-infiltrating CD8 T cells, activated T cells, activated blood CD8 T cells, anti-PD-1, cancer, circulating T cells, circulating immune cells, clonotypes, oral cancer, patients, treatment, tumor, tumor T cell clones, tumor-infiltrating T cell clonotypes, tumor-infiltrating and
Author NameAffiliation
Danielle DionneBroad Institute of Harvard and MIT
Orit Rozenblatt-RosenBroad Institute of Harvard and MIT
Ravindra UppaluriDana-Farber Cancer Institute, Brigham and Women's Hospital
Robert I HaddadDana-Farber Cancer Institute
Robert I HaddadDana-Farber Cancer Institute
Orr AshenbergBroad Institute of Harvard and MIT
Aviv RegevBroad Institute of Harvard and MIT, USA Howard Hughes Medical Institute and Koch Institute of Integrative Cancer Research, Massachusetts Institute of Technology
Aviv RegevBroad Institute of Harvard and MIT, USA Howard Hughes Medical Institute and Koch Institute of Integrative Cancer Research, Massachusetts Institute of Technology
Eliezer M Van AllenDana-Farber Cancer Institute
Eliezer M Van AllenDana-Farber Cancer Institute
  • 1 - 10

Datasets

Release 1.2